Transdermal Drug Patches to 2020 - WBOC-TV 16, Delmarvas News Leader, FOX 21 -

Transdermal Drug Patches to 2020

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, Feb. 11, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/n6j7k3/transdermal_drug

) has announced the addition of the

"Transdermal Drug Patches to 2020"

report to their offering.


(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Products, Indications, Markets and Forecasts



Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors - factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2020.



Highlights

  • Analyzes and evaluates prescription skin patch products and assesses risks and market potential
  • Analyzes patch designs, technologies and patch development issues
  • Provides assessments of transdermal drug patch products in two dozen key market segments
  • Provides market data and forecasts to 2020
  • Profiles patch manufacturers, their product development activities and strategies

Key Topics Covered:

Executive Summary

The Market Opportunity

Transdermal Drug Delivery Dynamics
Demand Drivers
Competitive Landscape
Factors Limiting Growth
Pharmacokinetics & Dosage Forms
Patch Manufacturing Dynamics
Patch Manufacturing Company Profiles

Product Analysis - FDA-Approved Drugs Delivered via Transdermal Patches

Alkaloids
Androgens
Antidepressants
Antiemetics
Antispasmodics
CNS Stimulants
Cholinesterase Inhibitors
Dopamine Agonists
Hormone Replacement
Hypotensive Agents
Local Anesthetics
NSAIDs
Opioid Analgesics
Progestrins
Trinitrates

Market Analysis - Transdermal Drug Patch Therapeutics

ADHD
Addiction
Contraception
Cardiovascular/Angina
Depression
Hormone Replacement Therapy
Hypertension
Motion Sickness
Neurology
Osteoporosis
Pain Management

Market Factors

Regulatory Issues
IP and Expiring Patents
Rx-to-OTC Switching
Patient Compliance and Ease of Use
Healthcare Economics

Profiles of Market Participants

For more information visit http://www.researchandmarkets.com/research/n6j7k3/transdermal_drug

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

All content © Copyright 2000 - 2014 Worldnow and WBOC. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service